|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4375 | (nenurodyta) |
| A61K 31/513 | (nenurodyta) | ||
| A61K 31/7068 | (nenurodyta) |
| (11) | Number of the document | 2049109 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07811049.1 |
| Date of filing the European patent application | 2007-08-02 | |
| (97) | Date of publication of the European application | 2009-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-18 |
| (46) | Date of publication of the claims translation | 2016-03-10 |
| (86) | Number | PCT/US2007/017344 |
| Date | 2007-08-02 |
| (87) | Number | WO 2008/016702 |
| Date | 2008-02-07 |
| (30) | Number | Date | Country code |
| 835239 P | 2006-08-02 | US | |
| 873760 P | 2006-12-08 | US |
| (72) |
ADELMAN, Daniel, C., US
SILVERMAN, Jeffrey, A., US
MICHELSON, Glenn, US
SCATENA, Caroline Darne, US
|
| (73) |
Sunesis Pharmaceuticals, Inc.,
395 Oyster Point Boulevard, Suite 400, South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | (+)-1,4-Dihidro-7-[(3s,4s)-3-metoksi-4-(metilamino)-1-pirolidinil]-4-okso-1-(2-tiazolil)-1,8-nafthidrin-3-karboksirūgšties ir citarabino (Ara-C) kombinuotas panaudojimas leukemijos gydymui |
| COMBINED USE OF (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID AND CYTARABINE (ARA-C) FOR THE TREATMENT OF LEUKEMIA |
| Payment date | Validity (years) | Amount | |
| 2018-07-20 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-11-12 |